New SA fund aims to lure big science names
12 August, 2002 by Melissa TrudingerA $1.5 million Biotechnology Fellowship Fund, launched last week by the South Australian government agency Bio Innovation SA, will bring three internationally renowned scientists to South Australia's universities.
Xcell looks to acquire European company
09 August, 2002 by Melissa TrudingerPerth based medical devices company Xcell Diagnostics has signed a letter of intent to acquire German company Visiomed in a deal that includes a combination of shares, options, cash and royalties.
IP strategies for the future
08 August, 2002 by Iain ScottWhen Dr Graeme Woodrow joined Biotech Australia as a bench scientist in 1983, a colleague told him: 'It would be a scandal for anyone to make a profit from a malaria vaccine."
IT awards seeking bio-IT involvement
06 August, 2002 by Iain ScottBio-IT innovators are being encouraged to enter this year's Asia-Pacific Australian Information Communication and Technology (ICT) Awards.
Optiscan appoints new chairman
06 August, 2002 by Tanya HollisA new chairman with science and manufacturing experience is to head the board of Optiscan.
Innovation patent system gets a workout
05 August, 2002 by Tanya HollisPatent attorneys will be watching closely this week as the legal status of the Federal Government's innovation patents system is tested for the first time in court.
Cutler joins CSIRO board
05 August, 2002 by Iain ScottFormer Industry, Research and Development Board chairman Dr Terry Cutler has been named as the fourth new appointee to the CSIRO board in the last two months.
NIH backs down from IP grab
02 August, 2002 by Melissa TrudingerThe US National Institutes of Health will defer implementing a policy that would allow it to limit ownership of patent rights and IP developed by NIH-funded Australian researchers.
de Kretser returns as Monash IR&D director
02 August, 2002 by Tanya HollisReproductive biologist Prof David de Kretser has returned to the director's role at the Monash Institute of Reproduction and Development.
AusBiotech gears up for conference
01 August, 2002 by Tanya HollisPeak industry organisation AusBiotech said it had secured 600 registrations so far to a conference it hopes to make an Australian biotechnology industry institution.
Perth PDF moves to become a biotech
31 July, 2002 by Pete YoungOne of Australia's oldest pooled development funds wants to toss in the towel as an investment vehicle to merge with its most promising holding, Perth biomed Clinical Cell Culture (C3).
More kudos for Cory
30 July, 2002 by Tanya HollisWalter and Eliza Hall Institute director Prof Suzanne Cory has been awarded a Royal Society medal in recognition of her work into the molecular basis for cancer.
Market forces: do biotechs list too early?
26 July, 2002 by Georgina DunnWhat's the difference between a biotech and a dot com? The average age of the board or directors. Funny? Maybe, but not exactly accurate. While there may be a sense of déjà vu - small start-ups looking for cash stampeding to the market - the biotech industry, unlike dot coms, is anything but an overnight phenomenon.
Mass spectrometry: the supply side
26 July, 2002 by Iain ScottIn the last 10 years, we've seen a dizzying array of new variations of mass spectrometry instruments, and at the same time as we've seen radical changes in scientific discovery. Mass spectrometry has become a key tool across the life sciences, from discovery to routine lab work. Consequently there seems to be an almost limitless range of permutations of mass spec.
Where have all the young minds gone?
24 July, 2002 by Melissa TrudingerThe decision to pursue post-doctoral studies overseas is one of the defining moments in a young Australian scientist's career.
